Skip to main content

Advertisement

Log in

The Clinical Approach to Encephalitis

  • Infection (J Halperin, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Encephalitis has various etiologies, but viral infections and autoimmune disorders are the most commonly identified. Clinical signs, geographical clues, and diagnostic testing—including cerebrospinal fluid abnormalities and magnetic resonance imaging abnormalities—can be helpful in identifying the cause. Certain forms of encephalitis have specific treatments; hence, establishing a diagnosis rapidly and accurately is crucial. Here, we describe the clinical approach to diagnosing several common etiologies of encephalitis as well as treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Schubert RD, Wilson MR. A tale of two approaches: How metagenomics and proteomics are shaping the future of encephalitis diagnostics. Curr Opin Neurol. 2015;28(3):283–7. Article outlines the impact of encephalitis and implication of future diagnostics including approaches with next-generation sequencing.

    Article  CAS  PubMed  Google Scholar 

  2. Cho TA, Mckendall RR. Clinical approach to the syndromes of viral encephalitis, myelitis, and meningitis. Handb Clin Neurol. 2014;123:89–121.

    Article  PubMed  Google Scholar 

  3. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: Consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57(8):1114–28. This article provides a consensus document based on the International Encephalitis Consortium for a standardized definition and diagnostic guideline for the evaulation of suspected encephalitis.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014;370(25):2408–17.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Widener RW, Whitley RJ. Herpes simplex virus. Handb Clin Neurol. 2014;123:251–63.

    Article  PubMed  Google Scholar 

  6. Steiner I. Herpes simplex virus encephalitis: New infection or reactivation? Curr Opin Neurol. 2011;24(3):268–74.

    Article  PubMed  Google Scholar 

  7. Bhattacharyya S, Lyons J. Neurology: Chapter 22 encephalitis. In: Scientific American Medicine. May 2015 ed.;2015.

  8. Whitley RJ, Soong SJ, Linneman Jr C, Liu C, Pazin G, Alford CA. Herpes simplex encephalitis. clinical assessment. JAMA. 1982;247(3):317–20.

    Article  CAS  PubMed  Google Scholar 

  9. Debiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev. 2004;17(4):903–25. table of contents.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Skoldenberg B. Herpes simplex encephalitis. Scand J Infect Dis Suppl. 1996;100:8–13.

    CAS  PubMed  Google Scholar 

  11. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National institute of allergy and infectious diseases collaborative antiviral study group. J Infect Dis. 1995;171(4):857–63.

    Article  CAS  PubMed  Google Scholar 

  12. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43(12):1565–77.

    Article  CAS  PubMed  Google Scholar 

  13. Jubelt B, Mihai C, Li TM, Veerapaneni P. Rhombencephalitis / brainstem encephalitis. Curr Neurol Neurosci Rep. 2011;11(6):543–52.

    Article  CAS  PubMed  Google Scholar 

  14. Hjalmarsson A, Blomqvist P, Skoldenberg B. Herpes simplex encephalitis in Sweden, 1990–2001: incidence, morbidity, and mortality. Clin Infect Dis. 2007;45(7):875–80.

    Article  PubMed  Google Scholar 

  15. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2008;47(3):303–27.

    Article  CAS  PubMed  Google Scholar 

  16. Ramos-Estebanez C, Lizarraga KJ, Merenda A. A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy? Antivir Ther. 2014;19(2):133–9.

    Article  CAS  PubMed  Google Scholar 

  17. Leypoldt F, Titulaer MJ, Aguilar E, et al. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology. 2013;81(18):1637–9.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Armangue T, Leypoldt F, Malaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2014;75(2):317–23. This study looked at both retrospective and prospective cases to identify a robust link between NMDAR antibody synthesis and relapsing symptoms in post HSVE patients.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology. 2015;84(4):359–66.

    Article  CAS  PubMed  Google Scholar 

  20. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8(8):731–40.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Tyler KL. Current developments in understanding of West Nile virus central nervous system disease. Curr Opin Neurol. 2014;27(3):342–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Rust RS. Human arboviral encephalitis. Semin Pediatr Neurol. 2012;19(3):130–51.

    Article  PubMed  Google Scholar 

  23. Kaiser R. Tick-borne encephalitis. Infect Dis Clin N Am. 2008;22(3):561–75. x.

    Article  Google Scholar 

  24. Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol. 2000;38(11):4066–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Tardei G, Ruta S, Chitu V, Rossi C, Tsai TF, Cernescu C. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of west nile virus infection. J Clin Microbiol. 2000;38(6):2232–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Golomb MR, Durand ML, Schaefer PW, McDonald CT, Maia M, Schwamm LH. A case of immunotherapy-responsive eastern equine encephalitis with diffusion-weighted imaging. Neurology. 2001;56(3):420–1.

    Article  CAS  PubMed  Google Scholar 

  27. Ben-Nathan D, Gershoni-Yahalom O, Samina I, et al. Using high titer west nile intravenous immunoglobulin from selected israeli donors for treatment of west nile virus infection. BMC Infect Dis. 2009;9:18. 2334-9-18.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Hart Jr J, Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014;14:248. 2334-14-248. Hart et al. report a large randomized, double-blinded, placebo-controlled clinical trial to assess the safety and potential therapeutic utility of passive immunotherapy in patients with WNV. This work is significant because it provides a negative study as the of using high titer WNV IVIg showed no statistical clinical benefit over placebo.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835–44.

    Article  PubMed  Google Scholar 

  30. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936–42.

    Article  CAS  PubMed  Google Scholar 

  31. Armstrong RW, Fung PC. Brainstem encephalitis (rhombencephalitis) due to listeria monocytogenes: Case report and review. Clin Infect Dis. 1993;16(5):689–702.

    Article  CAS  PubMed  Google Scholar 

  32. Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21(2):243–61. table of contents.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Menge T, Hemmer B, Nessler S, et al. Acute disseminated encephalomyelitis: an update. Arch Neurol. 2005;62(11):1673–80.

    Article  PubMed  Google Scholar 

  34. Debiasi RL, Tyler KL. Viral meningitis and encephalitis. In: Continuum: Infectious diseases. Vol 12. American Academy of Neurology Publications; 2006:58–94.

  35. Alexander M, Murthy JM. Acute disseminated encephalomyelitis: treatment guidelines. Ann Indian Acad Neurol. 2011;14 Suppl 1:S60–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Linnoila JJ, Rosenfeld MR, Dalmau J. Neuronal surface antibody-mediated autoimmune encephalitis. Semin Neurol. 2014;34(4):458–66.

    Article  PubMed  Google Scholar 

  37. Rosenfeld MR, Dalmau JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap Minn). 2012;18(2):366–83.

    Google Scholar 

  38. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis. 2012;54(7):899–904. This article provides important follow up data to the California Encephalitis Project in 2007 established to study the epidemiology of encephalitis. All cases between September 2007 and Febuary 2011 of individuals age less than 30 years old were reviewed. It was found that the number of anti-NMDAR encephalitis case exceeded viral etiologies. Thus, making anti-NMDAR encephaltis and important etiology to consider on the differential of encephalitis.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Wright S, Hacohen Y, Jacobson L, et al. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dis Child. 2015;100(6):521–6.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tracey A. Cho.

Ethics declarations

Conflict of Interest

Amanda L. Piquet and Tracey A. Cho declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Infection

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piquet, A.L., Cho, T.A. The Clinical Approach to Encephalitis. Curr Neurol Neurosci Rep 16, 45 (2016). https://doi.org/10.1007/s11910-016-0650-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-016-0650-9

Keywords

Navigation